|
CORRECTIONS: Metformin versus Insulin for the Treatment of Gestational Diabetes
Mercredi 02 Juillet 2008 - 06:55 - 5 mois depuis - Presse spécialisée - New England Journal of Medicin Metformin versus Insulin for the Treatment of Gestational Diabetes . In the abstract (page 2003), under Results, the parenthetical information should read "(relative risk, 0.99; 95% confidence interval, 0.80 to ... |
|
CME: Intensity of Renal Support in Critically Ill Patients with Acute Kidney Injury
Mercredi 02 Juillet 2008 - 06:55 - 5 mois depuis - Presse spécialisée - New England Journal of Medicin (No abstract is available for this citation) |
|
CME: Vasopressin and Epinephrine vs. Epinephrine Alone in Cardiopulmonary Resuscitation
Mercredi 02 Juillet 2008 - 06:55 - 5 mois depuis - Presse spécialisée - New England Journal of Medicin (No abstract is available for this citation) |
|
CME: A Gut Feeling
Mercredi 02 Juillet 2008 - 06:55 - 5 mois depuis - Presse spécialisée - New England Journal of Medicin (No abstract is available for this citation) |
|
PERSPECTIVE: Why Doctors Should Worry about Preemption
Mercredi 02 Juillet 2008 - 06:55 - 5 mois depuis - Presse spécialisée - New England Journal of Medicin A leading drug company may be poised to win a landmark legal victory next fall. If the drug manufacturer, Wyeth, prevails in a case soon to be argued before the ... |
|
PERSPECTIVE: Collective Accountability for Medical Care -- Toward Bundled Medicare Payments
Mercredi 02 Juillet 2008 - 06:55 - 5 mois depuis - Presse spécialisée - New England Journal of Medicin Medicare's projected spending growth is unsustainable. The program already strains the resources of beneficiaries and taxpayers alike and will someday crowd out other public- and private-sector priorities, given that Medicare ... |
|
ORIGINAL ARTICLE: Intensity of Renal Support in Critically Ill Patients with Acute Kidney Injury
Mercredi 02 Juillet 2008 - 06:55 - 5 mois depuis - Presse spécialisée - New England Journal of Medicin This randomized, controlled trial compared standard renal-replacement therapy with more intensive therapy in critically ill patients with acute kidney injury and failure of at least one nonrenal organ or sepsis. Intensive renal support did not decrease mortality, improve recovery of kidney function, or reduce the rate of nonrenal organ failure as compared with thrice-weekly intermittent hemodialysis. |
|
ORIGINAL ARTICLE: Vasopressin and Epinephrine vs. Epinephrine Alone in Cardiopulmonary Resuscitation
Mercredi 02 Juillet 2008 - 06:55 - 5 mois depuis - Presse spécialisée - New England Journal of Medicin In this clinical trial, a combination of epinephrine plus vasopressin was compared with epinephrine alone in out-of-hospital cardiopulmonary resuscitation. There was no benefit from the addition of vasopressin, and on the basis of these findings, this agent cannot be recommended in this clinical setting. |
|
ORIGINAL ARTICLE: Motesanib Diphosphate in Progressive Differentiated Thyroid Cancer
Mercredi 02 Juillet 2008 - 06:55 - 5 mois depuis - Presse spécialisée - New England Journal of Medicin This phase 2 trial investigated the efficacy of motesanib diphosphate, an orally active inhibitor of VEGF receptors, in patients with advanced differentiated thyroid cancer. None of the patients had had a response to conventional treatment. No patient had a complete response, but 14% had a partial response, with a median duration of 32 weeks. Motesanib diphosphate is an option for patients with metastatic or locally progressive differentiated thyroid cancer who have not had a response to usual treatment. |
|
ORIGINAL ARTICLE: A Population Study of Endomyocardial Fibrosis in a Rural Area of Mozambique
Mercredi 02 Juillet 2008 - 06:55 - 5 mois depuis - Presse spécialisée - New England Journal of Medicin Endomyocardial fibrosis is the most common cause of restrictive cardiomyopathy worldwide and in its advanced stages has a poor prognosis. This study used echocardiographic screening for endomyocardial fibrosis in Mozambique and found a prevalence of nearly 20%, much of which was mild to moderate in severity. These data may help to develop therapeutic or preventive approaches. |
< 1 – 11 – 21 – 31 – 41 – 51 – 61 – 71 – 81 – 91 – 101 – 111 – 121 – 131 – 141 – 151 – 152 – 153 – 154 – 155 – 156 – 157 – 158 – 159 – 160 – 161 – 162 – 163 – 164 – 165 – 166 – 167 – 168 – 169 – 170 – 171 – 172 – 173 – 174 – 175 – 176 – 177 – 187 – 197 – 207 – 217 – 227 – 237 – 247 – 257 – 267 – 277 – 287 – 297 – 307 – 317 – 327 >